LAVINIA IORDACHE: Open Payments
NPI 1770961203 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,806 in 18 payments from 7 companies in 2025. Trend: 2023 $571 · 2024 $3,325 · 2025 $1,806
Food & beverage: $756Consulting: $550Speaker / faculty: $500
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $778 |
| Ipsen Biopharmaceuticals, Inc | 1 | $500 |
| Madrigal Pharmaceuticals | 5 | $334 |
| Gilead Sciences, Inc. | 3 | $77 |
| Aimmune Therapeutics, Inc. | 2 | $59 |
| Intercept Pharmaceuticals, Inc. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $28 |
Products named: XIFAXAN, IQIRVO, REZDIFFRA, ZENPEP, OCALIVA, TREMFYA.
Industry payments across FL — which companies pay providers there.
